Palliative Chemotherapy Scientific Journals
Cancer specialists (oncologists) recommend
chemotherapy in one of two situations. For some cancers,
chemotherapy can completely get rid of the
cancer with a good chance that it will never come back. Examples include certain types of lymphoma,
leukaemia and testicular cancer, among others. For most cancers that have metastasized (spread beyond the original
cancer site),
chemotherapy cannot cure the cancer. However,
chemotherapy may be helpful in shrinking the cancer; improving or completely eliminating distressing symptoms caused by the
cancer for a period of time and helping you live longer. The use of
chemotherapy in these situations is named palliative chemotherapy.
Although the treatment of
chemotherapy side effects has vastly improved within the past 20 years, every patient responds differently. Ask your doctor to describe the most likely symptoms you will experience during
chemotherapy treatment.
Response Rate refers to the likelihood that your
cancer will improve from the treatment. A Response Rate of 30% means if 100 patients such as you were treated, 30 patients would have their
cancer shrink by one-half or more. For some cancers, the term response rates are often expanded to incorporate those patients whose
cancer didn't shrink, but also didn't grow. Talk to your oncologist to understand exactly how he/she is using the term response rate for your cancer.
High Impact List of Articles
-
Pharmacological treatment of left ventricular remodeling: recent trial results
Andrzej Tomasik & Ewa Nowalany-Kozielska
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of left ventricular remodeling: recent trial results
Andrzej Tomasik & Ewa Nowalany-Kozielska
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Parkinsons disease vaccine: clinical trial challenges when striving for disease modification
Achim Schneeberger, Alexandra Kutzelnigg,Markus Mandler
Editorial: Clinical Investigation
-
Parkinsons disease vaccine: clinical trial challenges when striving for disease modification
Achim Schneeberger, Alexandra Kutzelnigg,Markus Mandler
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, No 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, No 3
Acknowledgements: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
Relevant Topics in Clinical